Skip to main content

04-10-2012 | Diabetic foot | Book chapter | Article

2. Epidemiology and Health Care Cost of Diabetic Foot Problems

Authors: DPM, MPH, CPH, FACFAS Jeremy J. Cook, MD, MPH, Sc D Donald C. Simonson

Publisher: Humana Press


In 1992, Zimmet first referred to the “epidemic of diabetes,” noting that its costs both in terms of economic burden and human suffering are rising at an alarming rate (Zimmet, Diabetes Care. 1992;15(2):232–52). The global prevalence of diabetes mellitus has been projected to nearly double from a baseline of 2.8% in 2000 to 4.4% by 2030, affecting over 350 million individuals (Wild et al. Diabetes Care. 2004;27(5):1047–53). In the decade beginning in 1997, the prevalence of diabetes in the USA has increased by 48% (http://​apps.​nccd.​cdc.​gov/​DDTSTRS/​default.​aspx) (Fig. 2.1). Lower extremity morbidity contributes substantially to the toll diabetes takes on the individual and the health care system. This chapter focuses on the epidemiologic aspects of risk factors and complications in the diabetic lower extremity, particularly as they relate to the outcome of amputation. Included in the discussion is the influence of demographic factors, such as gender, age, race, and socioeconomic considerations, as well as the cost to the health care system of lower extremity disease in diabetes.

Please log in to get access to this content

Related topics